Sleep Disorders Trial, Recruiting NCT06471751 Sponsor: Centre Hospitalier Universitaire de Saint Etienne Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06471751
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with moderate sleep apnea, meaning their breathing interruption score (called an AHI) is between 15 and 30 per hour
  • People with a Body Mass Index (BMI) under 35
  • People who are covered by a social security or health insurance scheme
  • People who have agreed to take part and signed a consent form

Who may not be able to join:

  • People who experience significant daytime sleepiness, based on a standard sleepiness questionnaire score above 10 (called the Epworth scale)
  • People who drive professionally or have had accidents linked to falling asleep
  • People who have severe breathing problems caused by neuromuscular conditions, as confirmed by breathing function tests
  • People who are currently receiving treatment for sleep apnea, or whose doctor determines they need to start CPAP therapy or a jaw advancement device right away
  • People who stopped using CPAP or a jaw advancement device less than one month ago
  • People who are currently taking part in cardiorespiratory rehabilitation or who are starting a regular exercise training program
  • People with uncompensated heart failure, or who have had chest (sternum) surgery within the last 4 months
  • People with significant osteoporosis and a history of rib fractures
  • People with a history of spontaneous lung collapse (pneumothorax)
  • People with severe asthma

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amandine Zellag, Centre Hospitalier Universitaire de Saint Etienne

Phone: (0)4 77 12 73 93

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Registry
ClinicalTrials.gov
Start date
30 December 2024
Est. completion
1 August 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Apnea-Hypopnea Index (AHI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov